Cambridge startup Neurmind receives second tranche of Innovate UK funding

  1. Home
  2.  » 
  3. News
  4.  » Cambridge startup Neurmind receives second tranche of Innovate UK funding

Cambridge startup Neumind has received a second tranche of funding from Innovate UK, in an initiative promoting the UK’s most promising startups

The Neumind team is creating a platform to empower individuals with head injuries and neurological conditions to live a more functional and independent life. Founder Ellis Parry developed Neumind after his identical twin brother suffered a brain injury in 2012.

Innovate UK’s Young Innovators Next Steps Awards recognises trailblazing young entrepreneurs, accelerating their business growth to deliver big impact; these entrepreneurs were previous recipients of the Young Innovators Awards and have now been awarded a second time, based on their progress and their future growth plans.

Since winning his first award, Ellis has raised £250,000 of investment, released a prototype, gone from one user (his brother) to over 350, and developed an ambitious strategy to deliver cost-effective, long-term support in the neuro sector.

Neumind is building Alfred – an app that puts life-changing therapies in the hands of its users. Alfred uses ‘smart prompts’ – personalised multimedia messages delivered at a particular time or place. A smart prompt can be practical or therapeutic, such as a prompt that stimulates neural pathways associated with memory, a shopping list delivered when you enter your local shop, or a simple note to take the bins out.

Article from Business Weekly

Contact Us

Latest News

Small Business Grants

Small Business Grants

Small businesses already registered and trading in South Cambridgeshire are eligible to apply for grants of up to £5,000.

Creative East

Creative East

The Create Growth Programme is a £1.275m investment readiness and business support programme for creative industries in Norfolk, Suffolk, Cambridgeshire and Peterborough.

There are no upcoming events at this time.